Loading…
Based on limited metadata with no full letter text available, Warner Herb Co. received an FDA Warning Letter on February 21, 2020, regarding drug products. While the specific violations cannot be detailed without access to the complete letter, the warning indicates regulatory concerns related to drug manufacturing, labeling, or compliance. The FDA's Drug division issued this enforcement action, though the specific manufacturing or compliance deficiencies are not identifiable from the metadata alone.